In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Onc72 Prodrugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Onc72 Prodrugs ; day:20 ; month:01 ; year:2023 ; extent:10
Advanced healthcare materials ; (20.01.2023) (gesamt 10)
- Urheber
-
Mohammed, Gubran Khalil
Böttger, Roland
Krizsan, Andor
Volke, Daniela
Mötzing, Marina
Li, Shyh‐Dar
Knappe, Daniel
Hoffmann, Ralf
- DOI
-
10.1002/adhm.202202368
- URN
-
urn:nbn:de:101:1-2023012114011678407653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mohammed, Gubran Khalil
- Böttger, Roland
- Krizsan, Andor
- Volke, Daniela
- Mötzing, Marina
- Li, Shyh‐Dar
- Knappe, Daniel
- Hoffmann, Ralf
Ähnliche Objekte (12)
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Prodrugs and targeted delivery : towards better ADME properties
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Prodrugs mit einem Thiazolidingrundkörper : Synthese und In-vitro-Aktivität
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Synthese, in vitro Charakterisierung und in vivo Testung neuer Amidin-Prodrugs
Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Prodrugs and targeted delivery : towards better ADME properties
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Prodrugs mit einem Thiazolidingrundkörper : Synthese und In-vitro-Aktivität
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Synthese, in vitro Charakterisierung und in vivo Testung neuer Amidin-Prodrugs
Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
"Prodrugs" glycerolipidiques comme systeme pharmaceutique
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Prodrugs and targeted delivery : towards better ADME properties
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Prodrugs mit einem Thiazolidingrundkörper : Synthese und In-vitro-Aktivität
Aminoferrocen-basierte, krebsspezifische Prodrugs
Synthese von Entacapon-Prodrugs
Synthese, in vitro Charakterisierung und in vivo Testung neuer Amidin-Prodrugs
Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy
PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system